We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+5.81%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$13B
AUM Growth
+$984M
Cap. Flow
+$180M
Cap. Flow %
1.38%
Top 10 Hldgs %
38.14%
Holding
1,449
New
52
Increased
710
Reduced
341
Closed
132

Top Buys

Rank Stock Value
1
PLD icon
Prologis
PLD
+$287M
2
DLR icon
Digital Realty Trust
DLR
+$150M
3
HR icon
Healthcare Realty
HR
+$110M
4
WELL icon
Welltower
WELL
+$106M
5
O icon
Realty Income
O
+$88.1M

Sector Composition

Rank Sector Weight
1 Real Estate 57.53%
2 Technology 9.67%
3 Healthcare 4.73%
4 Financials 4.38%
5 Consumer Discretionary 3.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RPID icon
1351
Rapid Micro Biosystems
RPID
$103M
-101
Closed
SABS icon
1352
SAB Biotherapeutics
SABS
$264M
-13
Closed
SCHL icon
1353
Scholastic
SCHL
$766M
-250
Closed -$8K
SEER icon
1354
Seer Inc
SEER
$118M
-166
Closed -$1K
SID icon
1355
Companhia Siderúrgica Nacional
SID
$1.46B
-13,000
Closed -$31K
SPRO icon
1356
Spero Therapeutics
SPRO
$69.2M
-110
Closed
STTK icon
1357
Shattuck Labs
STTK
$651M
-123
Closed
SYRE icon
1358
Spyre Therapeutics
SYRE
$8.68B
-4
Closed
TCRT icon
1359
Alaunos Therapeutics
TCRT
$4.64M
$0 ﹤0.01%
3
TDOC icon
1360
Teladoc Health
TDOC
$1.69B
-9,075
Closed -$230K
TIL icon
1361
Instil Bio
TIL
$49.4M
$0 ﹤0.01%
19
TKNO icon
1362
Alpha Teknova
TKNO
$273M
-82
Closed
TNYA icon
1363
Tenaya Therapeutics
TNYA
$164M
-120
Closed
TRML
1364
DELISTED
Tourmaline Bio
TRML
-12
Closed
TSHA icon
1365
Taysha Gene Therapies
TSHA
$1.57B
-112
Closed
UHAL icon
1366
U-Haul Holding Co
UHAL
$14.3B
-4,980
Closed -$254K
URGN icon
1367
UroGen Pharma
URGN
$1.99B
$0 ﹤0.01%
48
VOR icon
1368
Vor Biopharma
VOR
$1.08B
-5
Closed
VSTM icon
1369
Verastem
VSTM
$547M
-27
Closed
WMS icon
1370
Advanced Drainage Systems
WMS
$11.1B
-14,400
Closed -$1.79M
XOS icon
1371
Xos
XOS
$28.2M
-312
Closed -$11K
YMAB
1372
DELISTED
Y-mAbs Therapeutics
YMAB
-149
Closed -$2K
YUMC icon
1373
Yum China
YUMC
$15.6B
-2,523
Closed -$119K
QTTB icon
1374
Q32 Bio
QTTB
$467M
-6
Closed
PDYN icon
1375
Palladyne AI
PDYN
$239M
-1,332
Closed -$18K

Similar funds

Daiwa Securities Group's Q4 2022 Portfolio in Review

As of Q4 2022, Daiwa Securities Group held 1,449 positions worth $13B, up 8.2% from $12B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Daiwa Securities Group's Q4 2022 filing shows 52 new, 710 increased, 341 reduced and 132 closed positions. Its largest new stake was Atlassian: 9,371 shares worth $1.21M. The largest sale was Duke Realty Corp., an estimated $310M.

By sector, the portfolio is most concentrated in Real Estate at 58% of assets, down from 59% a quarter earlier, followed by Technology and Healthcare.

  • Daiwa Securities Group's largest Q4 2022 buy was Atlassian: 9,371 shares worth $1.21M.
  • Daiwa Securities Group added most to Prologis in Q4 2022, an estimated $287M increase.
  • Daiwa Securities Group's biggest Q4 2022 reduction was Simon Property Group, cutting an estimated $93.4M.
  • Daiwa Securities Group fully exited Duke Realty Corp. in Q4 2022, selling an estimated $310M.
  • Daiwa Securities Group's ten largest holdings make up 38% of its $13B portfolio in Q4 2022.
  • Daiwa Securities Group opened 52 new positions and closed 132 in Q4 2022.
  • Daiwa Securities Group's portfolio value rose 8.2% quarter-over-quarter to $13B.

Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.